IL32
Interleukin-32
Also known as: IL32_HUMAN, NK4, TAIF, TAIFb, TAIFd
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24001
- Gene
- IL32
- Ensembl
- ENSG00000008517
- Chromosome
- 16
- Canonical length
- 234 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the cytokine family. The protein contains a tyrosine sulfation site, 3 potential N-myristoylation sites, multiple putative phosphorylation sites, and an RGD cell-attachment sequence. Expression of this protein is increased after the activation of T-cells by mitogens or the activation of NK cells by IL-2. This protein induces the production of TNFalpha from macrophage cells. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
234 residues, UniProt reviewed canonical sequence.
>P24001|IL32
1 MCFPKVLSDD MKKLKARMVM LLPTSAQGLG AWVSACDTED TVGHLGPWRD KDPALWCQLC
61 LSSQHQAIER FYDKMQNAES GRGQVMSSLA ELEDDFKEGY LETVAAYYEE QHPELTPLLE
121 KERDGLRCRG NRSPVPDVED PATEEPGESF CDKVMRWFQA MLQRLQTWWH GVLAWVKEKV
181 VALVHAVQAL WKQFQSFCCS LSELFMSSFQ SYGAPRGDKE ELTPQKCSEP QSSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL32 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 831 nTPM
Expression across tissuesHPA
Tissue
- liver: 831 nTPM
- pancreas: 686 nTPM
- small intestine: 526 nTPM
- skeletal muscle: 510 nTPM
- spleen: 415 nTPM
- kidney: 415 nTPM
Single-cell type
- enterocytes: 4,883 nCPM
- pancreatic acinar cells: 1,531 nCPM
- colonocytes: 1,213 nCPM
- t-cells: 984 nCPM
- pancreatic duct cells: 848 nCPM
- nk-cells: 571 nCPM
Immune cell
- T-reg: 4,640 nTPM
- MAIT T-cell: 2,590 nTPM
- gdT-cell: 2,578 nTPM
- memory CD8 T-cell: 2,483 nTPM
- memory CD4 T-cell: 2,345 nTPM
- total PBMC: 2,240 nTPM
Brain region
- thalamus: 24 nTPM
- medulla oblongata: 22 nTPM
- pons: 20 nTPM
- cerebral cortex: 18 nTPM
- spinal cord: 16 nTPM
- amygdala: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL32.
Disease | ImmuneIEDB
Conditions an epitope on IL32 was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.35
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- defense response
- immune response
- negative regulation of viral life cycle
- positive regulation of gene expression
- positive regulation of type III interferon production
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interleukin-32
- Interleukin 32
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL32 as an antibody target. Whether an autoantibody or antibody against IL32 could matter depends on whether native IL32 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL32 is annotated as secreted, so native IL32 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL32 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...